Published in Zdrav Prac on September 01, 1973
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer (1984) 1.14
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer (1984) 0.86
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years. Arch Gesamte Virusforsch (1972) 0.82
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants. Arch Gesamte Virusforsch (1972) 0.80
Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences. Vaccine (1988) 0.78
[The modern vaccination calendar, indications and contraindications for vaccination]. Cesk Pediatr (1986) 0.75
[Neurologic complications after vaccinations]. Cesk Pediatr (1991) 0.75
[Vaccination of children with impaired health using the ADTP (Diphtheria, Tetanus, Pertussis) vaccine]. Cesk Pediatr (1976) 0.75
[Contraindications for vaccination]. Cesk Pediatr (1989) 0.75
[Comparison of clinical and serological results after intramuscular and subcutaneous administration of measles vaccine]. Cesk Pediatr (1982) 0.75
[The present vaccination schedule for children]. Cesk Pediatr (1980) 0.75
[The epidemiologic situation in Czechoslovakia 1982-1986]. Cesk Pediatr (1987) 0.75
[Influenza vaccination of children with a sub-unit vaccine made in Czechoslovakia]. Cesk Pediatr (1981) 0.75
[Immunologic findings in children with abnormal reactions after vaccination]. Cesk Pediatr (1993) 0.75
[Vaccination against measles in nursery schools in Prague 10]. Cas Lek Cesk (1972) 0.75
Negative seroconversion and circulating interferon in children vaccinated with live measles vaccine. J Hyg Epidemiol Microbiol Immunol (1977) 0.75
[Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles]. Cesk Pediatr (1975) 0.75
[Reactivity and immunologic activity of polyvalent split influenza vaccine in children]. Cesk Pediatr (1990) 0.75
[Use of live measles vaccine in the 3d injection of basic DTPA vaccine (Diphtheria, Tetanus, Pertussia Antitoxin)]. Cesk Pediatr (1973) 0.75
Persistence of measles antibody after immunization. J Biol Stand (1975) 0.75
[Vaccination of repeatedly negative children against smallpox]. Cesk Pediatr (1977) 0.75
[Neurologic disorders after vaccination against measles and mumps]. Cesk Pediatr (1992) 0.75
Antibody response to Epstein-Barr virus antigens in patients with chronic viral infection. J Med Virol (1988) 0.75
[Follow-up of a group of children with severe reactions to mixed vaccine against diphtheria, tetanus and whooping cough from the aspect of their immunological profile]. Cesk Pediatr (1988) 0.75
[Neurologic complications after vaccination against diphtheria, tetanus and whooping cough]. Cesk Pediatr (1992) 0.75
[Study of transplacentally transmitted rubella antibody levels in children during their 1st year of life]. Cesk Pediatr (1982) 0.75
[New technics for filling variola vaccines]. Cesk Pediatr (1970) 0.75
[Annual experience with measles vaccination]. Cesk Pediatr (1971) 0.75
[Clinical reactivity and immunological activity of 2 subunit influenza vaccine in infants]. Cesk Pediatr (1973) 0.75
[Changes in tetanus antibody levels after the administration of tetanus antigen in children]. Cesk Pediatr (1988) 0.75
[Real and putative contraindications to vaccination]. Cesk Pediatr (1988) 0.75
[Use of the Sevac Immunoskintest kit in children]. Cesk Pediatr (1989) 0.75
[Immunization against diphtheria and tetanus in children with severe neurological disorders]. Cesk Pediatr (1992) 0.75
[Vaccination against measles]. Cesk Pediatr (1977) 0.75
[Measles vaccination with attenuated and live vaccine simultaneously with use of the ADTP vaccine containing parapertussis component]. Cesk Epidemiol Mikrobiol Imunol (1971) 0.75
Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses. Dev Biol Stand (1978) 0.75
[Vaccination of children with reactions to mixed vaccine against diphtheria, tetanus and whooping cough]. Cesk Pediatr (1988) 0.75
[60 years of immunobiologic production in Czechoslovakia]. Cesk Pediatr (1986) 0.75
[Rubella prophylactic immunization problems in the Czechoslovak SSR: experiences with Ra 2713 and Cendehill rubella vaccines]. Z Gesamte Hyg (1980) 0.75
[Experience with Czechoslovak subunit anti-influenza vaccine (author's transl)]. Cas Lek Cesk (1975) 0.75
[Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC]. Cesk Pediatr (1968) 0.75
[Detection of the clinical reaction and antibody response in whole-virion influenza trivaccine]. Cesk Pediatr (1986) 0.75
[Comparison of the clinical reactivity and immunological effectiveness of adsorbed and non-adsorbed sub-unit influenza vaccine]. Cesk Pediatr (1983) 0.75
[The epidemiologic situation in Czechoslovakia in 1987]. Cesk Pediatr (1989) 0.75
[Vaccination in children with neurologic diseases]. Cesk Pediatr (1992) 0.75
Secretory antibody response to haemagglutinin of influenza virus A/swine and A/victoria in humans after administration of split and whole-virion vaccine. J Biol Stand (1978) 0.75
Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses. J Biol Stand (1978) 0.75
[Secondary measles immunization of 8th grade students in elementary schools]. Cesk Pediatr (1981) 0.75
[Comparison of the immunologic effectiveness of SUBINVIRA type B (sub-unit influenza virus vaccine) in children after administration of various doses]. Cesk Pediatr (1984) 0.75